$33.72 0.49 (+1.47%)
11/6/2009 4:00 PM

Auxilium Pharmaceuticals, Inc. (AUXL)

CAPS Rating: 1 out of 5

A specialty biopharmaceutical company with a focus on developing and marketing products to urologists, endocrinologists, orthopedists and select primary care physicians.

Current Price $33.72 Mkt Cap $1.44B
Open $33.05 P/E Ratio 0.00
Prev. Close $33.23 Div. (Yield) N/A (N/A)
Daily Range $32.87 - $33.80 Volume 269,311
52-Wk Range $17.96 - $37.28 Avg. Daily Vol. 429,000

AUXL News and Commentary

Caps

How do you think AUXL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

107 Outperform
69 Underperform
 

All-Star Members

11 Outperform
36 Underperform
 

Wall Street

11 Outperform
3 Underperform
 

Top AUXL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mblin13 (36.29)
Submitted March 01, 2007

downside provided by testim;
other drugs in phase 3 trials;
stock could triple

0 Comments | Reply | Report this Post

alvinbentley (99.93)
Submitted April 29, 2008

Do any investors out there know anything about Dupuytren's contracture? It is not very common. Most patients who need intervention would be referred to an orthopedic surgeon. If Xiaflex were actually FDA approved, the surgeon could recommend either… More

1 Comment | Reply | Report this Post
AUXL VS S&P 500 (SPY)

Fools bullish on AUXL are also bullish on:

Fools bearish on AUXL are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about AUXL.

Recs

0
Member Avatar EclecticRecluse (75.00) Submitted: 10/5/2009 5:17:05 PM : Underperform Start Price: $33.92 AUXL Score: +2.84

Negative Earnings Surprise

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar lonewulf47638 (59.64) Submitted: 9/14/2009 1:09:20 PM : Underperform Start Price: $35.77 AUXL Score: +8.62

Rise too steep on hand disorder drug

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar mrindependent (98.79) Submitted: 9/1/2009 1:02:34 PM : Underperform Start Price: $28.54 AUXL Score: -10.80

Considering Auxiliam Pharmaceuticals has never earned money, it is simply overvalued at 45 times book value.

Report this Post 0 Comments | Reply | Permalink
View All 20 Pitches »

Leaderboard

Find the members with the highest scoring picks in AUXL.

Score Leader

Weatheredwood

Weatheredwood (< 20) Score: +235.16

The Score Leader is the member with the highest score across all their picks in AUXL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Weatheredwood < 20 9/20/2006 Outperform 3M $10.50 +221.14% -14.02% +235.16
skyyhi < 20 10/17/2006 Outperform 1Y $12.14 +177.76% -16.60% +194.36
mblin13 36.29 3/1/2007 Outperform 3Y $12.32 +173.70% -19.23% +192.94 1 Comment
krishanl 25.97 1/16/2007 Outperform 1Y $13.97 +141.37% -20.52% +161.90
msraman < 20 1/29/2007 Outperform 1Y $14.00 +140.86% -20.03% +160.89
martinlemalin 40.18 1/22/2007 Outperform 1Y $14.20 +137.46% -20.52% +157.99 1 Comment
slash32is4 75.78 12/12/2006 Outperform NS $14.57 +131.43% -19.75% +151.18
727whi 36.26 6/5/2007 Outperform NS $15.37 +119.39% -26.17% +145.56
OneStarHero < 20 5/29/2007 Outperform 5Y $15.72 +114.50% -25.46% +139.96
SanjayChandran 45.37 7/9/2007 Outperform 1Y $16.08 +109.70% -26.24% +135.95
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackCarisandCo 78.62 7/20/2009 Underperform NS $29.22 +15.40% +13.69% -1.71
TrackHapoalim 51.20 6/25/2009 Outperform NS $27.78 +21.38% +20.05% +1.34
TrackZacks 69.52 5/6/2009 Outperform 3M $22.64 +49.82% +16.63% +33.20 10/13/2009 @ $33.92 1 Comment
TrackFTNEquityCa 25.15 4/1/2009 Underperform NS $23.28 +44.85% +35.08% -9.77
TrackFTNEquityCa 25.15 3/12/2009 Outperform NS $27.45 -11.73% +8.49% -20.22 4/1/2009 @ $24.23
TrackStanfordRes 80.42 11/14/2008 Outperform NS $22.09 +52.65% +22.91% +29.74
TrackLeerinkSwan 84.26 11/10/2008 Outperform NS $21.79 +54.75% +15.50% +39.25
TrackDeutscheSec 89.50 11/3/2008 Outperform NS $21.35 +57.94% +13.45% +44.49
TrackBreanMurray 89.84 9/30/2008 Underperform NS $33.28 +1.32% -3.37% -4.69
TrackOppenheimer 26.63 9/11/2008 Outperform NS $36.72 -8.17% -9.48% +1.31
TrackCollinsStew 68.32 8/13/2008 Outperform NS $40.73 -17.21% -14.05% -3.16
TrackPacificGrow 90.86 5/15/2008 Outperform NS $30.14 +11.88% -21.31% +33.19
TrackSoleil 83.54 3/24/2008 Outperform NS $22.50 +49.87% -16.66% +66.53
TrackMerriman < 20 3/24/2008 Underperform NS $22.50 +60.62% +5.60% -55.02 6/5/2008 @ $36.14
TrackJefferies 75.83 1/15/2008 Outperform NS $28.91 +16.64% -20.13% +36.77
TrackRothCapital 75.81 11/1/2007 Underperform NS $24.58 -13.14% -35.12% -21.98 11/3/2008 @ $21.35
TrackSoros 65.62 9/30/2007 Outperform NS $21.08 +59.96% -26.44% +86.40 1 Comment
TrackZacks 69.52 9/25/2007 Underperform 3M $20.40 +49.90% -2.46% -52.36 12/28/2007 @ $30.58 1 Comment
TrackCowenandCo 74.62 6/21/2007 Outperform NS $14.92 +126.01% -25.36% +151.36
TrackBofASec 93.50 5/25/2007 Outperform NS $16.57 +153.89% -14.66% +168.55 8/14/2008 @ $42.07
TrackCitigroup 21.22 5/10/2007 Outperform NS $13.87 +143.84% -15.27% +159.10 7/24/2008 @ $33.82
TrackRothCapital 75.81 11/20/2006 Underperform NS $16.71 -17.41% +3.73% +21.15 2/16/2007 @ $13.80

Featured Broker Partners